Psoriatic Arthritis (PsA) Treatment Market - Global Outlook and Forecast 2023-2028

Report ID: 1369966 | Published Date: Jan 2025 | No. of Page: 61 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Psoriatic Arthritis (PsA) Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Psoriatic Arthritis (PsA) Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Psoriatic Arthritis (PsA) Treatment Overall Market Size
    2.1 Global Psoriatic Arthritis (PsA) Treatment Market Size: 2021 VS 2028
    2.2 Global Psoriatic Arthritis (PsA) Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Psoriatic Arthritis (PsA) Treatment Players in Global Market
    3.2 Top Global Psoriatic Arthritis (PsA) Treatment Companies Ranked by Revenue
    3.3 Global Psoriatic Arthritis (PsA) Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Psoriatic Arthritis (PsA) Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Psoriatic Arthritis (PsA) Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Psoriatic Arthritis (PsA) Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Psoriatic Arthritis (PsA) Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Psoriatic Arthritis (PsA) Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Psoriatic Arthritis (PsA) Treatment Market Size Markets, 2021 & 2028
        4.1.2 Nonsteriodal Anti-inflammatory Drugs
        4.1.3 Disease Modifying Antirheumatic Drugs
        4.1.4 Biologics
    4.2 By Type - Global Psoriatic Arthritis (PsA) Treatment Revenue & Forecasts
        4.2.1 By Type - Global Psoriatic Arthritis (PsA) Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Psoriatic Arthritis (PsA) Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Psoriatic Arthritis (PsA) Treatment Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Psoriatic Arthritis (PsA) Treatment Revenue & Forecasts
        5.2.1 By Application - Global Psoriatic Arthritis (PsA) Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Psoriatic Arthritis (PsA) Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Psoriatic Arthritis (PsA) Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Psoriatic Arthritis (PsA) Treatment Revenue & Forecasts
        6.2.1 By Region - Global Psoriatic Arthritis (PsA) Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Psoriatic Arthritis (PsA) Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Psoriatic Arthritis (PsA) Treatment Revenue, 2017-2028
        6.3.2 US Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
        6.3.3 Canada Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
        6.3.4 Mexico Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Psoriatic Arthritis (PsA) Treatment Revenue, 2017-2028
        6.4.2 Germany Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
        6.4.3 France Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
        6.4.4 U.K. Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
        6.4.5 Italy Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
        6.4.6 Russia Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
        6.4.8 Benelux Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Psoriatic Arthritis (PsA) Treatment Revenue, 2017-2028
        6.5.2 China Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
        6.5.3 Japan Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
        6.5.4 South Korea Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
        6.5.6 India Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Psoriatic Arthritis (PsA) Treatment Revenue, 2017-2028
        6.6.2 Brazil Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
        6.6.3 Argentina Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Psoriatic Arthritis (PsA) Treatment Revenue, 2017-2028
        6.7.2 Turkey Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
        6.7.3 Israel Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
        6.7.5 UAE Psoriatic Arthritis (PsA) Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporate Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Major Product Offerings
        7.1.4 Pfizer Psoriatic Arthritis (PsA) Treatment Revenue in Global Market (2017-2022)
        7.1.5 Pfizer Key News
    7.2 Johnson & Johnson
        7.2.1 Johnson & Johnson Corporate Summary
        7.2.2 Johnson & Johnson Business Overview
        7.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Major Product Offerings
        7.2.4 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue in Global Market (2017-2022)
        7.2.5 Johnson & Johnson Key News
    7.3 AbbVie
        7.3.1 AbbVie Corporate Summary
        7.3.2 AbbVie Business Overview
        7.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Major Product Offerings
        7.3.4 AbbVie Psoriatic Arthritis (PsA) Treatment Revenue in Global Market (2017-2022)
        7.3.5 AbbVie Key News
    7.4 Novartis
        7.4.1 Novartis Corporate Summary
        7.4.2 Novartis Business Overview
        7.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Major Product Offerings
        7.4.4 Novartis Psoriatic Arthritis (PsA) Treatment Revenue in Global Market (2017-2022)
        7.4.5 Novartis Key News
    7.5 UCB
        7.5.1 UCB Corporate Summary
        7.5.2 UCB Business Overview
        7.5.3 UCB Psoriatic Arthritis (PsA) Treatment Major Product Offerings
        7.5.4 UCB Psoriatic Arthritis (PsA) Treatment Revenue in Global Market (2017-2022)
        7.5.5 UCB Key News
    7.6 Roche
        7.6.1 Roche Corporate Summary
        7.6.2 Roche Business Overview
        7.6.3 Roche Psoriatic Arthritis (PsA) Treatment Major Product Offerings
        7.6.4 Roche Psoriatic Arthritis (PsA) Treatment Revenue in Global Market (2017-2022)
        7.6.5 Roche Key News
    7.7 Bristol-Myers Squibb
        7.7.1 Bristol-Myers Squibb Corporate Summary
        7.7.2 Bristol-Myers Squibb Business Overview
        7.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Major Product Offerings
        7.7.4 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue in Global Market (2017-2022)
        7.7.5 Bristol-Myers Squibb Key News
    7.8 Eli Lilly
        7.8.1 Eli Lilly Corporate Summary
        7.8.2 Eli Lilly Business Overview
        7.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Major Product Offerings
        7.8.4 Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue in Global Market (2017-2022)
        7.8.5 Eli Lilly Key News
    7.9 Amgen
        7.9.1 Amgen Corporate Summary
        7.9.2 Amgen Business Overview
        7.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Major Product Offerings
        7.9.4 Amgen Psoriatic Arthritis (PsA) Treatment Revenue in Global Market (2017-2022)
        7.9.5 Amgen Key News
    7.10 AstraZeneca
        7.10.1 AstraZeneca Corporate Summary
        7.10.2 AstraZeneca Business Overview
        7.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Major Product Offerings
        7.10.4 AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue in Global Market (2017-2022)
        7.10.5 AstraZeneca Key News
    7.11 Celgene
        7.11.1 Celgene Corporate Summary
        7.11.2 Celgene Business Overview
        7.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Major Product Offerings
        7.11.4 Celgene Psoriatic Arthritis (PsA) Treatment Revenue in Global Market (2017-2022)
        7.11.5 Celgene Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Psoriatic Arthritis (PsA) Treatment Market Opportunities & Trends in Global Market
    Table 2. Psoriatic Arthritis (PsA) Treatment Market Drivers in Global Market
    Table 3. Psoriatic Arthritis (PsA) Treatment Market Restraints in Global Market
    Table 4. Key Players of Psoriatic Arthritis (PsA) Treatment in Global Market
    Table 5. Top Psoriatic Arthritis (PsA) Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Psoriatic Arthritis (PsA) Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Psoriatic Arthritis (PsA) Treatment Product Type
    Table 9. List of Global Tier 1 Psoriatic Arthritis (PsA) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Psoriatic Arthritis (PsA) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Psoriatic Arthritis (PsA) Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Psoriatic Arthritis (PsA) Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Psoriatic Arthritis (PsA) Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Psoriatic Arthritis (PsA) Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Psoriatic Arthritis (PsA) Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Psoriatic Arthritis (PsA) Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Pfizer Corporate Summary
    Table 31. Pfizer Psoriatic Arthritis (PsA) Treatment Product Offerings
    Table 32. Pfizer Psoriatic Arthritis (PsA) Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Johnson & Johnson Corporate Summary
    Table 34. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product Offerings
    Table 35. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. AbbVie Corporate Summary
    Table 37. AbbVie Psoriatic Arthritis (PsA) Treatment Product Offerings
    Table 38. AbbVie Psoriatic Arthritis (PsA) Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. Novartis Corporate Summary
    Table 40. Novartis Psoriatic Arthritis (PsA) Treatment Product Offerings
    Table 41. Novartis Psoriatic Arthritis (PsA) Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. UCB Corporate Summary
    Table 43. UCB Psoriatic Arthritis (PsA) Treatment Product Offerings
    Table 44. UCB Psoriatic Arthritis (PsA) Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. Roche Corporate Summary
    Table 46. Roche Psoriatic Arthritis (PsA) Treatment Product Offerings
    Table 47. Roche Psoriatic Arthritis (PsA) Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. Bristol-Myers Squibb Corporate Summary
    Table 49. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product Offerings
    Table 50. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue (US$, Mn), (2017-2022)
    Table 51. Eli Lilly Corporate Summary
    Table 52. Eli Lilly Psoriatic Arthritis (PsA) Treatment Product Offerings
    Table 53. Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue (US$, Mn), (2017-2022)
    Table 54. Amgen Corporate Summary
    Table 55. Amgen Psoriatic Arthritis (PsA) Treatment Product Offerings
    Table 56. Amgen Psoriatic Arthritis (PsA) Treatment Revenue (US$, Mn), (2017-2022)
    Table 57. AstraZeneca Corporate Summary
    Table 58. AstraZeneca Psoriatic Arthritis (PsA) Treatment Product Offerings
    Table 59. AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue (US$, Mn), (2017-2022)
    Table 60. Celgene Corporate Summary
    Table 61. Celgene Psoriatic Arthritis (PsA) Treatment Product Offerings
    Table 62. Celgene Psoriatic Arthritis (PsA) Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Psoriatic Arthritis (PsA) Treatment Segment by Type in 2021
    Figure 2. Psoriatic Arthritis (PsA) Treatment Segment by Application in 2021
    Figure 3. Global Psoriatic Arthritis (PsA) Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Psoriatic Arthritis (PsA) Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Psoriatic Arthritis (PsA) Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Psoriatic Arthritis (PsA) Treatment Revenue in 2021
    Figure 8. By Type - Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Psoriatic Arthritis (PsA) Treatment Revenue Market Share, 2017-2028
    Figure 12. US Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Psoriatic Arthritis (PsA) Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Psoriatic Arthritis (PsA) Treatment Revenue Market Share, 2017-2028
    Figure 24. China Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Psoriatic Arthritis (PsA) Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Psoriatic Arthritis (PsA) Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Psoriatic Arthritis (PsA) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Pfizer Psoriatic Arthritis (PsA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. AbbVie Psoriatic Arthritis (PsA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Novartis Psoriatic Arthritis (PsA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. UCB Psoriatic Arthritis (PsA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Roche Psoriatic Arthritis (PsA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Amgen Psoriatic Arthritis (PsA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Celgene Psoriatic Arthritis (PsA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
61
Frequently Asked Questions
Psoriatic Arthritis Treatment Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Psoriatic Arthritis Treatment Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Psoriatic Arthritis Treatment Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports